Healthcare AI startups that earn FDA approval are like jobseekers after landing a new job. 

The past 12 months have brought numerous exciting advances involving AI and related emerging technologies. Let us not fail to take a short last look at some of the more spectacular flops. 

Who is Sriram Krishnan, and why is he headed to the White House? 

Some investment analysts are predicting a more permissive M&A market, deregulation as a catalyst for growth and fiscal policies that stimulate economic activity. And they see AI as a catalyst in the shift. 

Nurses are making their peace with workplace AI. 

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Will the second Trump Administration manage AI’s risks—or ‘unshackle’ AI’s potential? 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.